The case for newborn screening for severe combined immunodeficiency and related disorders

Annals of the New York Academy of Sciences

Volumn 1246, Issue 1, 2011, Pages 108-117

  Puck, Jennifer M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dried blood spot; Lymphocytopenia; Newborn screening; Primary immunodeficiency; Severe combined immunodeficiency (SCID); T cell receptor excision circle (TREC)

Indexed keywords

BIOLOGICAL MARKER; T LYMPHOCYTE RECEPTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; DNA ISOLATION; ENZYME REPLACEMENT; FATALITY; GENE THERAPY; GENOTYPE; HEALTH PROGRAM; HUMAN; IMMUNE SYSTEM; LYMPHOCYTOPENIA; NEWBORN; NEWBORN SCREENING; NONHUMAN; SEVERE COMBINED IMMUNODEFICIENCY; T LYMPHOCYTE;

EID: 84855317098     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06346.x     Document Type: Article

References (37)

1. Guthrie, R. & I. Susi. 1963. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32: 318-343.
2. Newborn Screening Status Report (updated 3/01/10). National Newborn Screening and Genetics Resource Center. Available at: [Accessed Sept. 26, 2011].
3. Howell, R.R. & M.A. Lloyd-Puryear. 2010. From developing guidelines to implementing legislation: actions of the US Advisory Committee on Heritable Disorders in Newborns and Children toward advancing and improving newborn screening. Semin Perinatol. 34: 121-124.
4. Lipstein, E.A., M.F. Browning, N.S. Green, et al. 2010. Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency. Pediatrics 125: 1226-1235.
5. Buckley, R.H. 2011. Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes. Immunol. Res. 49: 25-43.
6. Gaspar, H.B, A. Aiuti, F. Porta, et al. 2009. How I treat ADA deficiency. Blood 114: 3524-3532.
7. Fischer, A., S. Hacein-Bey-Abina & M. Cavazzana-Calvo. 2011. Gene therapy for primary adaptive immune deficiencies. J. Allergy Clin. Immunol. 127: 1356-1359.
8. Buckley, R.H., R.I. Schiff, S.E. Schiff, et al. 1997. Human severe combined immunodeficiency: genetic, phenotypic and functional diversity in one hundred eight infants. J. Pediatr. 130: 378-387.
9. Lindegren, M.L., L. Kobrynski, S.A. Rasmussen, et al. 2004. Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm. Rep. 53: 1-29.
10. Puck, J.M. & Newborn Screening Working Group. 2007. SCID population-based newborn screening for severe combined immunodeficiency: steps toward implementation. J. Allergy Clin. Immunol. 120: 760-768.
11. Myers, L.A., D.D. Patel, J.M. Puck & R.H. Buckley. 2002. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 99: 872-878.
12. Brown, L., J. Xu-Bayford, Z. Allwood, et al. 2011. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening. Blood 117: 3243-3246.
13. Chan, A., C. Scalchunes, M. Boyle & J.M. Puck. 2011. Early vs. delayed diagnosis of severe combined immunodeficiency: a family perspective survey. Clin. Immunol. 138: 3-8.
14. McGhee, S.A., E.R. Stiehm & E.R. McCabe. 2005. Potential costs and benefits of newborn screening for severe combined immunodeficiency. J. Pediatr. 147: 603-608.
15. Chan, K., J. Davis, S.Y. Pai, et al. 2011. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol. Genet. Metab. Jul 12. [Epub ahead of print, PMID: 21810544].
16. Werther, R.L., N.W. Crawford, K. Boniface, et al. 2009. Rotavirus vaccine induced diarrhea in a child with severe combined immune deficiency. J. Allergy Clin. Immunol. 124: 600.
17. Patel, N.C., P.M. Hertel, M.K. Estes, et al. 2010. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N. Engl. J. Med. 362: 314-319.
18. Janik, D.K., B. Lindau-Shepard, A.M. Comeau & K.A. Pass. 2010. A multiplex immunoassay using the Guthrie specimen to detect T-cell deficiencies including severe combined immunodeficiency disease. Clin. Chem. 56: 1460-1465.
19. Lebet, T., R. Chiles, A.P. Hsu, et al. 2008. Mutations causing severe combined immunodeficiency: detection with a custom resequencing microarray. Genet. Med. 10: 575-585.
20. Chan, K. & J.M. Puck. 2005. Development of population-based newborn screening for severe combined immunodeficiency. J. Allergy Clin. Immunol. 115: 391-398.
21. Douek, D.C., R.D. McFarland, P.H. Keiser, et al. 1998. Changes in thymic function with age and during the treatment of HIV infection. Nature 396: 690-695.
22. Morinishi Y., K. Imai, N. Nakagawa, et al. 2009. Identification of severe combined immunodeficiency by T-cell receptor excision circles quantification using neonatal Guthrie cards. J. Pediatr. 155: 829-833.
23. Baker, M.W., W.J. Grossman, R.H. Laessig, et al. 2009. Development of a routine newborn screening protocol for severe combined immunodeficiency. J. Allergy Clin. Immunol. 124: 522-527.
24. Gerstel-Thompson, J.L., J.C. Baptiste, J.S. Navas, et al. 2010. High-throughput multiplexed T-cell-receptor excision circle quantitative PCR assay with internal controls for detection of severe combined immunodeficiency in population-based newborn screening. Clin. Chem. 56: 1466-1474.
25. Chase, N.M., J.W. Verbsky & J.M. Routes. 2010. Newborn screening for T-cell deficiency. Curr. Opin. Allergy Clin. Immunol. 10: 521-525.
26. Li, L., D. Moshous, Y. Zhou, et al. 2002. A founder mutation in Artemis, an SNM1-like protein, causes SCID in Athabascan-speaking native Americans. J. Immunol. 168: 6323-6329.
27. Hale, J.E., F.A. Bonilla, S.Y. Pai, et al. 2010. Identification of an infant with severe combined immunodeficiency by newborn screening. J. Allergy Clin. Immunol. 126: 1073-1074.
28. Routes, J.M., J. Verbsky, R.H. Laessig, et al. 2009. Statewide newborn screening for severe T-cell lymphopenia. JAMA 302: 2465-2470.
29. McDonald-McGinn, D.M. & K.E. Sullivan. 2011. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine 90: 1-18.
30. Ram, G. & J. Chinen. 2011. Infections and immunodeficiency in Down syndrome. Clin. Exp. Immunol. 164: 9-16.
31. Dasouki, M., K.C. Okonkwo, A. Ray, et al. 2011. Deficient T cell receptor excision circles (TRECs) in autosomal recessive hyper IgE syndrome caused by DOCK8 mutation: implications for pathogenesis and potential detection by newborn screening. Clin. Immunol. 141: 128-132.
32. Primary Immune Deficiency Treatment Consortium. Available at: [Accessed Sept. 30, 2011].
33. Griffith, L.M., M.J. Cowan, D.B. Kohn, et al. 2008. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. J. Allergy Clin. Immunol. 122: 1087-1096.
34. Buckley, R.H. 2010. B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a review. J. Allergy Clin. Immunol. 125: 790-797.
35. Therrell, B.L., Jr., W.H. Hannon, D.B. Bailey Jr., et al. 2011. Committee report: considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening. Genet. Med. 13: 621-624.
36. Hiraki, S., & N.S. Green. 2010. Newborn screening for treatable genetic conditions: past, present and future. Obstet. Gynecol. Clin. North Am. 37: 11-21.
37. Modell F., D. Puente & V. Modell. 2009. From genotype to phenotype. Further studies measuring the impact of a Physician Education and Public Awareness Campaign on early diagnosis and management of primary immunodeficiencies. Immunol. Res. 44: 132-149.